Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Sports
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Teleflex
(NYSE:TFX)
Intraday
$226.17
2.30
[1.03%]
After-Hours
$226.17
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$226.17
2.30
[1.03%]
At close: Mar 28
$226.17
0
[0.00%]
After Hours: 4:04PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Teleflex Stock (NYSE:TFX)
Teleflex Stock (NYSE: TFX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, March 28, 2024
Teleflex Announced Its Near- And Long-term Climate Change Targets Have Been Validated By The Science Based Targets Initiative
Benzinga Newsdesk
-
10 hours ago
Monday, February 26, 2024
Teleflex: Dividend Insights
Benzinga Insights
-
Feb 26, 2024, 9:45AM
Friday, February 23, 2024
JMP Securities Reiterates Market Outperform on Teleflex, Maintains $285 Price Target
Benzinga Newsdesk
-
Feb 23, 2024, 12:45PM
RBC Capital Maintains Outperform on Teleflex, Lowers Price Target to $265
Benzinga Newsdesk
-
Feb 23, 2024, 11:41AM
Breaking Down Teleflex: 4 Analysts Share Their Views
Benzinga Insights
-
Feb 23, 2024, 9:00AM
Thursday, February 22, 2024
Teleflex shares are trading lower after the company reported Q4 financial results and issued FY24 EPS guidance below estimates.
Benzinga Newsdesk
-
Feb 22, 2024, 10:22AM
Teleflex FY24 Outlook: Adj. EPS $13.55 - $13.95 Vs. $13.84 Estimate, GAAP EPS $5.69 - $6.09 Vs. $10.10 Estimate, Revenue Growth 3.60% - 4.60%
Benzinga Newsdesk
-
Feb 22, 2024, 6:33AM
Teleflex Q4 Adj. EPS $3.38 Beats $3.26 Estimate, Sales $773.91M Beat $768.69M Estimate
Benzinga Newsdesk
-
Feb 22, 2024, 6:30AM
Earnings Scheduled For February 22, 2024
Benzinga Insights
-
Feb 22, 2024, 5:27AM
Wednesday, February 21, 2024
Preview: Teleflex's Earnings
Benzinga Insights
-
Feb 21, 2024, 12:01PM
Tuesday, January 23, 2024
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Vandana Singh
-
Jan 23, 2024, 2:56PM
Friday, January 12, 2024
Forecasting The Future: 10 Analyst Projections For Teleflex
Benzinga Insights
-
Jan 12, 2024, 12:00PM
RBC Capital Maintains Outperform on Teleflex, Raises Price Target to $272
Benzinga Newsdesk
-
Jan 12, 2024, 11:32AM
Tuesday, January 09, 2024
Teleflex Says Titan SGS Stapler—A Purpose-Built Stapler For Gastric Tissue With A Specific Indication For Sleeve Pouch Creation In Bariatric Procedures—Is Now Available With Staple Line Reinforcement
Benzinga Newsdesk
-
Jan 9, 2024, 6:39AM
Friday, December 22, 2023
Truist Securities Maintains Hold on Teleflex, Raises Price Target to $270
Benzinga Newsdesk
-
Dec 22, 2023, 10:11AM
Wednesday, December 20, 2023
EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
-
Dec 20, 2023, 7:50AM
The Analyst Verdict: Teleflex In The Eyes Of 7 Experts
Benzinga Insights
-
Dec 20, 2023, 7:00AM
Raymond James Maintains Outperform on Teleflex, Raises Price Target to $271
Benzinga Newsdesk
-
Dec 20, 2023, 4:17AM
Thursday, December 07, 2023
Teleflex 13G Filing Shows Janus Henderson Group Plc Reported A 10.3% Stake In The Company As Of November 30, 2023
Benzinga Newsdesk
-
Dec 7, 2023, 2:53PM
Tuesday, December 05, 2023
Teleflex Was Awarded The Peripheral Access Purchasing Agreement With Premier Effective December 1st, 2023
Benzinga Newsdesk
-
Dec 5, 2023, 6:32AM
Monday, December 04, 2023
Analyst Expectations for Teleflex's Future
Benzinga Insights
-
Dec 4, 2023, 3:01PM
Morgan Stanley Upgrades Teleflex to Overweight
Benzinga Newsdesk
-
Dec 4, 2023, 7:25AM
Thursday, November 16, 2023
Teleflex Enrolls First Patient In A Clinical Registry Intended To Examine And Collect Data On Outcomes Of Contemporary On-label Use Of MANTA Vascular Closure Device In Standard Of Care Transcatheter Aortic Valve Replacement Procedures
Benzinga Newsdesk
-
Nov 16, 2023, 6:32AM
Thursday, November 09, 2023
Teleflex's Ex-Dividend Date Is Tuesday, Here's What You Need To Know
Benzinga Insights
-
Nov 9, 2023, 9:45AM
Monday, November 06, 2023
FDA Says Teleflex, And Arrow International, Recall Pressure Injectable Catheter Kits For Mislabeling; FDA Has Identified Recall Of Pressure Injectable Catheter Kits For Mislabeling As Class I Recall
Benzinga Newsdesk
-
Nov 6, 2023, 4:23PM
Piper Sandler Maintains Neutral on Teleflex, Raises Price Target to $225
Benzinga Newsdesk
-
Nov 6, 2023, 10:52AM
Truist Securities Maintains Hold on Teleflex, Raises Price Target to $221
Benzinga Newsdesk
-
Nov 6, 2023, 9:23AM
Friday, November 03, 2023
JMP Securities Maintains Market Outperform on Teleflex, Lowers Price Target to $285
Benzinga Newsdesk
-
Nov 3, 2023, 3:51PM
RBC Capital Maintains Outperform on Teleflex, Raises Price Target to $228
Benzinga Newsdesk
-
Nov 3, 2023, 3:34PM
Analyst Ratings for Teleflex
Benzinga Insights
-
Nov 3, 2023, 3:00PM
Stephens & Co. Reiterates Overweight on Teleflex, Maintains $275 Price Target
Benzinga Newsdesk
-
Nov 3, 2023, 12:30PM
Thursday, November 02, 2023
Starbucks, Teleflex, Roku, Shopify And Other Big Stocks Moving Higher On Thursday
Lisa Levin
-
Nov 2, 2023, 11:01AM
Teleflex Inc Expects FY23 Constant Currency Revenue Growth 6.4%-6.6% YoY (Prior 5.50%-6.25%) Vs $2.96B Est, Adj EPS $13.30-$13.50 (Prior $13.00-$13.60) Vs $13.26 Est
Benzinga Newsdesk
-
Nov 2, 2023, 6:44AM
Teleflex Q3 Adj EPS $3.64 Beats $3.27 Estimate, Sales $746.39M Beat $733.56M Estimate
Benzinga Newsdesk
-
Nov 2, 2023, 6:34AM
Earnings Scheduled For November 2, 2023
Benzinga Insights
-
Nov 2, 2023, 4:56AM
Wednesday, November 01, 2023
Earnings Preview: Teleflex
Benzinga Insights
-
Nov 1, 2023, 1:01PM
Wednesday, October 11, 2023
Analyst Ratings for Teleflex
Benzinga Insights
-
Oct 11, 2023, 11:00AM
Stephens & Co. Reiterates Overweight on Teleflex, Maintains $315 Price Target
Benzinga Newsdesk
-
Oct 11, 2023, 8:25AM
Friday, September 15, 2023
Teleflex Gets Selected To Exhibit Arrow VPS Rhythm DLX Device And Arrow PICCs Preloaded With NaviCurve Stylet At Vizient Innovative Technology Exchange To Be Held On Oct. 3 In Grapevine, Texas
Benzinga Newsdesk
-
Sep 15, 2023, 6:47AM
Monday, August 21, 2023
Teleflex Reports Extension Of Arrow ErgoPack Complete System To Hemodialysis And Large Bore Central Venous Catheters
Benzinga Newsdesk
-
Aug 21, 2023, 6:33AM
Wednesday, August 09, 2023
Teleflex: Dividend Insights
Benzinga Insights
-
Aug 9, 2023, 10:45AM
Monday, August 07, 2023
Truist Securities Maintains Hold on Teleflex, Lowers Price Target to $255
Benzinga Newsdesk
-
Aug 7, 2023, 11:14AM
Expert Ratings for Teleflex
Benzinga Insights
-
Aug 7, 2023, 11:00AM
Raymond James Maintains Outperform on Teleflex, Lowers Price Target to $255
Benzinga Newsdesk
-
Aug 7, 2023, 4:23AM
Friday, August 04, 2023
JMP Securities Maintains Outperform on Teleflex, Lowers Price Target to $315
Benzinga Newsdesk
-
Aug 4, 2023, 7:39AM
Thursday, August 03, 2023
Earnings Scheduled For August 3, 2023
Benzinga Insights
-
Aug 3, 2023, 6:59AM
Teleflex Raises 2023 GAAP Revenue Growth Guidance To 5.80%-6.55% From 4.65%-5.90%, Expects GAAP EPS From Continuing Ops Of $7.33-$7.93 Vs. $8.14-$8.74 Prior Range; Maintains Adjusted EPS Guidance Of $13.00-$13.60 Vs. Consensus Of $13.31
Benzinga Newsdesk
-
Aug 3, 2023, 6:41AM
Teleflex Q2 Adjusted EPS $3.41 Beats $3.21 Estimate, Sales $743.26M Beat $729.40M Estimate
Benzinga Newsdesk
-
Aug 3, 2023, 6:34AM
Tuesday, August 01, 2023
The FDA Has Cleared Teleflex's QuikClot Control+ Hemostatic Device To Include Mild, Moderate Bleeding In Cardiac Surgical Procedures And Bone Surface Bleeding Following A Sternotomy
Benzinga Newsdesk
-
Aug 1, 2023, 6:54AM
Thursday, July 27, 2023
Teleflex's Interventional Urology Portfolio Expansion Earns Overweight Rating From Bullish Analyst
Nabaparna Bhattacharya
-
Jul 27, 2023, 3:29PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch